WHO ICTRP trial
Effect of kunxian capsule and leflunomide on IgA nephropathy
ChiCTR1800019606 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800019606 |
|---|---|
| Public title | Effect of kunxian capsule and leflunomide on IgA nephropathy |
| Scientific title | Effect of kunxian capsule and leflunomide on IgA nephropathy |
| Primary sponsor | The First Affiliated Hospital of Chengdu Medical College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | IgA nephropathy |
| Interventions | 1:Kun-Xian Capsule;2:Leflunomide |
| Registration date | Nov 19, 2018 |
| Target size | 1:20;2:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: